682 related articles for article (PubMed ID: 30427217)
1. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
[TBL] [Abstract][Full Text] [Related]
2. Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy.
Chen W; Guo N; Qi M; Dai H; Hong M; Guan L; Huan X; Song S; He J; Wang Y; Xi Y; Yang X; Shen Y; Su Y; Sun Y; Gao Y; Chen Y; Ding J; Tang Y; Ren G; Miao Z; Li J
Eur J Med Chem; 2017 Sep; 138():514-531. PubMed ID: 28692916
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel dual target inhibitors of PARP and HSP90 and their antitumor activities.
Lin S; Zhang L; Zhang X; Yu Z; Huang X; Xu J; Liu Y; Chen L; Wu L
Bioorg Med Chem; 2020 May; 28(9):115434. PubMed ID: 32222339
[TBL] [Abstract][Full Text] [Related]
5. Development of novel synthesized phthalazinone-based PARP-1 inhibitors with apoptosis inducing mechanism in lung cancer.
Almahli H; Hadchity E; Jaballah MY; Daher R; Ghabbour HA; Kabil MM; Al-Shakliah NS; Eldehna WM
Bioorg Chem; 2018 Apr; 77():443-456. PubMed ID: 29453076
[TBL] [Abstract][Full Text] [Related]
6. Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies.
Soliman AM; Abd El-Wahab HAA; Akincioglu H; Gülçin İ; Omar FA
Bioorg Chem; 2024 Jan; 142():106916. PubMed ID: 37913584
[TBL] [Abstract][Full Text] [Related]
7. Ionic liquid-enabled synthesis, cholinesterase inhibitory activity, and molecular docking study of highly functionalized tetrasubstituted pyrrolidines.
Kumar RS; Almansour AI; Arumugam N; Althomili DMQ; Altaf M; Basiri A; D K; Sai Manohar T; S V
Bioorg Chem; 2018 Apr; 77():263-268. PubMed ID: 29421701
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
[TBL] [Abstract][Full Text] [Related]
9. New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease.
Jalili-Baleh L; Nadri H; Moradi A; Bukhari SNA; Shakibaie M; Jafari M; Golshani M; Homayouni Moghadam F; Firoozpour L; Asadipour A; Emami S; Khoobi M; Foroumadi A
Eur J Med Chem; 2017 Oct; 139():280-289. PubMed ID: 28803044
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel phthalazinone derivatives as potent poly(ADP-ribose)polymerase 1 inhibitors.
Xin M; Sun J; Huang W; Tang F; Liu Z; Jin Q; Wang J
Future Med Chem; 2020 Oct; 12(19):1691-1707. PubMed ID: 33012191
[No Abstract] [Full Text] [Related]
11. Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease.
Zhu J; Yang H; Chen Y; Lin H; Li Q; Mo J; Bian Y; Pei Y; Sun H
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):496-506. PubMed ID: 29405075
[TBL] [Abstract][Full Text] [Related]
12. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
13. Olaparib hydroxamic acid derivatives as dual PARP and HDAC inhibitors for cancer therapy.
Yuan Z; Chen S; Sun Q; Wang N; Li D; Miao S; Gao C; Chen Y; Tan C; Jiang Y
Bioorg Med Chem; 2017 Aug; 25(15):4100-4109. PubMed ID: 28601509
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, cytotoxicity and molecular modelling studies of new phenylcinnamide derivatives as potent inhibitors of cholinesterases.
Saeed A; Mahesar PA; Zaib S; Khan MS; Matin A; Shahid M; Iqbal J
Eur J Med Chem; 2014 May; 78():43-53. PubMed ID: 24675179
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.
Nisa MU; Munawar MA; Iqbal A; Ahmed A; Ashraf M; Gardener QA; Khan MA
Eur J Med Chem; 2017 Sep; 138():396-406. PubMed ID: 28688279
[TBL] [Abstract][Full Text] [Related]
16. A Series of New Hydrazone Derivatives: Synthesis, Molecular Docking and Anticholinesterase Activity Studies.
Bozbey İ; Özdemir Z; Uslu H; Özçelik AB; Şenol FS; Orhan İE; Uysal M
Mini Rev Med Chem; 2020; 20(11):1042-1060. PubMed ID: 31660824
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
18. Design, Synthesis and Activity Evaluation of New Phthalazinone PARP Inhibitors.
Huang M; Ren J; Wang Y; Chen X; Yang J; Tang T; Yang Z; Li X; Ji M; Cai J
Chem Pharm Bull (Tokyo); 2021; 69(7):620-629. PubMed ID: 34193711
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.
Razavi SF; Khoobi M; Nadri H; Sakhteman A; Moradi A; Emami S; Foroumadi A; Shafiee A
Eur J Med Chem; 2013 Jun; 64():252-9. PubMed ID: 23644208
[TBL] [Abstract][Full Text] [Related]
20. In silico identification of AChE and PARP-1 dual-targeted inhibitors of Alzheimer's disease.
Hu XM; Dong W; Cui ZW; Gao CZ; Yu ZJ; Yuan Q; Min ZL
J Mol Model; 2018 Jun; 24(7):151. PubMed ID: 29869722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]